T. Obayashi et al., PLASMA (1-]3)-BETA-D-GLUCAN MEASUREMENT IN DIAGNOSIS OF INVASIVE DEEPMYCOSIS AND FUNGAL FEBRILE EPISODES, Lancet, 345(8941), 1995, pp. 17-20
(1-->3)-beta-D-glucan is a characteristic fungal cell-wall constituent
. To assess the clinical usefulness of this glucan in screening for in
vasive fungal infection or fungal febrile episodes, we measured the pl
asma concentration at the time of routine blood culture in 202 febrile
episodes by means of factor G, a horseshoe-crab coagulation enzyme th
at is extremely sensitive to this polysaccharide. With a plasma cut-of
f value of 20 pg/mL, 37 of 41 of definite fungal infections (confirmed
at or by microbiology) had positive results of 59 episodes of non-fun
gal fever, or collagen diseases had concentrations below the cut-off v
alue (specificity 100%). Of 102 episodes of fever of unknown origin, 2
6 had plasma glucan concentrations of more than 20 pg/mL. With those 1
02 cases taken as non-fungal infections, the positive predictive Value
of the test was estimated as 59% (37/63), the negative predictive val
ue as 97% (135/139), and the efficiency as 85% (172/202). The positive
predictive Value should improve if there were a sensitive gold standa
rd that could discriminate fungal from non-fungal infections. Causativ
e fungi included candida, aspergillus, cryptococcus, and trichosporon.
Determination of plasma (1-->3)-beta-D-glucan with factor G is a high
ly sensitive and specific test for invasive deep mycosis and fungal fe
brile episodes, and will substantially benefit immunocompromised patie
nts.